Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients - BioSpace Get link Facebook X Pinterest Email Other Apps June 20, 2020 Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients BioSpace Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment